首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of psychoactive drugs

缩写:

ISSN:0279-1072

e-ISSN:2159-9777

IF/分区:2.2/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引671
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Patrick W Corrigan,Sai Snigdha Talluri,Beatrice Wendeln et al. Patrick W Corrigan et al.
Attitudes about cannabis use (CU) are changing, as exemplified by laws in some states and the District of Columbia (DC) legalizing medicinal cannabis with or without recreational use. This study contrasts the effect of changes in DC and sta...
Nicky J Mehtani,Maha N Mian,Gabrielle Agin-Liebes et al. Nicky J Mehtani et al.
Amid an evolving psychedelic drug policy landscape and limitations of existing substance use disorder (SUD) treatments, a novel addiction recovery paradigm has emerged involving augmentation of 12-Step program engagement with therapeutic ps...
James M Zech,Jérémie Richard,Grant M Jones James M Zech
Psychedelic-assisted interventions are emerging as potential treatments for substance use disorders, including alcohol use disorder (AUD). While recent randomized controlled trials suggest efficacy for certain psychedelics and related compo...
Barbara Brett,Christine Bynum Barbara Brett
Posttraumatic stress disorder (PTSD) is a serious and chronic mental health condition with limited effective treatment options. 3,4-methylenedioxymethamphethamine (MDMA)-assisted psychotherapy (MDMA-AT) has shown promise in phase 2 and phas...
John Moore,Namkee Choi,Diana DiNitto John Moore
Approximately 18% of U.S. adults have a substance use disorder (SUD), yet SUD treatment utilization rates remain low. Substance use problem recognition, or one's awareness that their substance use is harmful, is a key precursor to seeking S...
A M Ortiz Bernal,C L Raison,R L Lancelotta et al. A M Ortiz Bernal et al.
5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a psychedelic gaining interest as a potential mental health treatment. However, a poorly characterized phenomenon termed reactivation (similar to "flashbacks") is commonly reported with 5-MeO-...
Anna Bradford,Ethan Freedman,Rachel E Dinero Anna Bradford
In recent years, the potential psychological benefits of psychedelic drugs have garnered increasing interest from academic and medical communities. We conducted a systematic review of literature examining the association between psychedelic...
Giulia Carla Zaffaina,Luis J Gómez Pérez,Sonia Chindamo et al. Giulia Carla Zaffaina et al.
Craving is a core characteristic in Cocaine Use Disorder (CUD) associated to relapse and treatment adherence. The assessment of craving is challenging due to the complexities arising from the various theoretical perspectives. Valid and reli...
Kirsten E Smith,Katherine Hill,Cecilia L Bergeria et al. Kirsten E Smith et al.
Among adults who have used tianeptine, we aimed to determine demographic and substance-use patterns and gain insights into tianeptine doses, effects, and consumer conceptualizations. We also evaluated problematic use, quit attempts, and tia...
Mitch Earleywine,Caitlin Holley,Henry MacConnel et al. Mitch Earleywine et al.
MDMA-assisted therapy (MDMA-AT) for post-traumatic stress disorder (PTSD) shows promise, but attitudes and beliefs about this treatment, especially in symptomatic veterans, remain poorly understood. We sought to explore relevant attitudes i...